UBS Group’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Sell |
384,062
-312,646
| -45% | -$19.2M | ﹤0.01% | 2717 |
|
|
2026
Q1 | $45.5M | Buy |
696,708
+234,946
| +51% | +$17.2M | 0.01% | 1743 |
|
|
2025
Q4 | $37.2M | Sell |
461,762
-336,755
| -42% | -$27.1M | 0.01% | 1955 |
|
|
2025
Q3 | $65.5M | Buy |
798,517
+246,286
| +45% | +$21.3M | 0.01% | 1378 |
|
|
2025
Q2 | $50.4M | Sell |
552,231
-32,937
| -6% | -$2.94M | 0.01% | 1516 |
|
|
2025
Q1 | $53.5M | Sell |
585,168
-163,249
| -22% | -$14.2M | 0.01% | 1419 |
|
|
2024
Q4 | $63.7M | Buy |
748,417
+288,728
| +63% | +$25.3M | 0.01% | 1249 |
|
|
2024
Q3 | $40.2M | Buy |
459,689
+120,075
| +35% | +$10.1M | 0.01% | 1305 |
|
|
2024
Q2 | $26.8M | Buy |
339,614
+99,754
| +42% | +$8.2M | 0.01% | 1453 |
|
|
2024
Q1 | $21.7M | Sell |
239,860
-166,885
| -41% | -$15.2M | 0.01% | 1624 |
|
|
2023
Q4 | $35.7M | Buy |
406,745
+157,691
| +63% | +$13.1M | 0.01% | 1191 |
|
|
2023
Q3 | $21M | Buy |
249,054
+56,731
| +29% | +$5.12M | 0.01% | 1440 |
|
|
2023
Q2 | $19M | Sell |
192,323
-11,895
| -6% | -$1.12M | 0.01% | 1487 |
|
|
2023
Q1 | $19.6M | Sell |
204,218
-81,650
| -29% | -$7.55M | 0.01% | 1408 |
|
|
2022
Q4 | $26M | Buy |
285,868
+36,842
| +15% | +$3.13M | 0.01% | 1230 |
|
|
2022
Q3 | $19.8M | Buy |
249,026
+96,466
| +63% | +$8.17M | 0.01% | 1285 |
|
|
2022
Q2 | $12.7M | Sell |
152,560
-61,213
| -29% | -$5.05M | 0.01% | 1637 |
|
|
2022
Q1 | $17.6M | Buy |
213,773
+22,415
| +12% | +$1.76M | 0.01% | 1524 |
|
|
2021
Q4 | $14.3M | Buy |
191,358
+122,448
| +178% | +$9.19M | ﹤0.01% | 1833 |
|
|
2021
Q3 | $5.22M | Buy |
68,910
+1,580
| +2% | +$122K | ﹤0.01% | 2626 |
|
|
2021
Q2 | $5.21M | Sell |
67,330
-106,002
| -61% | -$8.18M | ﹤0.01% | 2638 |
|
|
2021
Q1 | $12.2M | Sell |
173,332
-20,905
| -11% | -$1.58M | ﹤0.01% | 1791 |
|
|
2020
Q4 | $13.8M | Buy |
194,237
+102,539
| +112% | +$6.44M | ﹤0.01% | 1604 |
|
|
2020
Q3 | $5.26M | Sell |
91,698
-41,045
| -31% | -$2.45M | ﹤0.01% | 2154 |
|
|
2020
Q2 | $8.08M | Buy |
132,743
+4,936
| +4% | +$305K | ﹤0.01% | 1679 |
|
|
2020
Q1 | $7.03M | Buy |
127,807
+95,388
| +294% | +$6.39M | ﹤0.01% | 1653 |
|
|
2019
Q4 | $2.34M | Buy |
32,419
+92
| +0.3% | +$6.26K | ﹤0.01% | 3395 |
|
|
2019
Q3 | $2.14M | Buy |
32,327
+4,204
| +15% | +$270K | ﹤0.01% | 3221 |
|
|
2019
Q2 | $1.75M | Buy |
28,123
+2,740
| +11% | +$158K | ﹤0.01% | 3268 |
|
|
2019
Q1 | $1.37M | Sell |
25,383
-43,287
| -63% | -$2.43M | ﹤0.01% | 3320 |
|
|
2018
Q4 | $4.02M | Buy |
68,670
+18,932
| +38% | +$1.19M | ﹤0.01% | 2352 |
|
|
2018
Q3 | $3.28M | Sell |
49,738
-1,981
| -4% | -$131K | ﹤0.01% | 2738 |
|
|
2018
Q2 | $3.42M | Sell |
51,719
-78,865
| -60% | -$5.31M | ﹤0.01% | 2681 |
|
|
2018
Q1 | $8.71M | Sell |
130,584
-25,249
| -16% | -$1.7M | ﹤0.01% | 1821 |
|
|
2017
Q4 | $10.2M | Buy |
155,833
+36,342
| +30% | +$2.36M | ﹤0.01% | 1699 |
|
|
2017
Q3 | $7.69M | Buy |
119,491
+66,637
| +126% | +$4.3M | ﹤0.01% | 1824 |
|
|
2017
Q2 | $3.41M | Sell |
52,854
-57,812
| -52% | -$3.65M | ﹤0.01% | 2493 |
|
|
2017
Q1 | $6.75M | Sell |
110,666
-118,346
| -52% | -$7.11M | ﹤0.01% | 1820 |
|
|
2016
Q4 | $13.3M | Buy |
229,012
+102,357
| +81% | +$6.04M | 0.01% | 1291 |
|
|
2016
Q3 | $7.33M | Sell |
126,655
-48,826
| -28% | -$2.88M | ﹤0.01% | 1678 |
|
|
2016
Q2 | $10.1M | Buy |
175,481
+38,067
| +28% | +$2.18M | 0.01% | 1373 |
|
|
2016
Q1 | $8.3M | Sell |
137,414
-6,802
| -5% | -$381K | 0.01% | 1452 |
|
|
2015
Q4 | $7.87M | Buy |
144,216
+18,141
| +14% | +$1.04M | 0.01% | 1583 |
|
|
2015
Q3 | $7.17M | Sell |
126,075
-456
| -0.4% | -$26.1K | 0.01% | 1637 |
|
|
2015
Q2 | $6.91M | Buy |
126,531
+83,759
| +196% | +$4.61M | ﹤0.01% | 1782 |
|
|
2015
Q1 | $2.33M | Buy |
42,772
+34,992
| +450% | +$1.77M | ﹤0.01% | 2794 |
|
|
2014
Q4 | $363K | Buy |
+7,780
| New | +$364K | ﹤0.01% | 4487 |
|
Other funds holding DOX
BGC
BIP
UBS Group's DOX Position: Q2 2026 in Review
UBS Group reduced its Amdocs (DOX) stake by 45% in Q2 2026, selling an estimated $19.2M and leaving 384,062 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2717.
UBS Group first reported a position in DOX in Q4 2014 and has held it in 47 quarters since. The position peaked at $65.5M in Q3 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- UBS Group held 384,062 shares of Amdocs worth $19.4M as of Q2 2026.
- UBS Group sold 312,646 Amdocs shares in Q2 2026, an estimated $19.2M.
- Amdocs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2717 holding.
- UBS Group first reported a position in Amdocs in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Amdocs position peaked at $65.5M in Q3 2025.
- 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.